Metabolic-Fit / 100
Mevo Health review
A Delaware-registered program naming four real physicians, with semaglutide and tirzepatide each offered as an injection or oral tablet from a disclosed floor price ($199/$259 'as low as') — but no full pricing ladder, no state list, and no confirmation the required consult is included.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Mevo Health at a glance
- Semaglutide
- As low as $199/mo
- Tirzepatide
- As low as $259/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
How we scored Mevo Health
Each factor is scored from Mevo Health's real pricing, disclosures and oversight, then combined into the 37/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.mevohealth.com
Re-verified live 2026-08-05. Operating entity: Mevo Health LLC (Delaware). Names four physicians: Dr. David Wasef (head of the Mevo Provider Network), Dr. Frank Suppa, Dr. Andrew Sakla, and Dr. Constantin Chikando (Internal/Family/Emergency Medicine). Dr. Wasef and Dr. Suppa also appear on Vytora Health's and Ondra Health's sites — an ordinary moonlighting-physician pattern across DTC telehealth brands, not evidence of a shared or duplicate company; Mevo Health LLC is confirmed as a distinct Delaware entity. Pharmacy partners are described only as plural '503A U.S. compounding pharmacies,' names not surfaced in text. Prescription products require an online consultation per the site, but whether that consult is free/included is not stated either way. No state-availability table or '50 states' claim found anywhere on the site. LegitScript seal confirmed present on homepage, contact, and footer. Contact care@mevohealth.com, 845-570-3714.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Injection, floor priceAdvertised as 'As low as $199/mo' — a floor price only; no full per-dose ladder is disclosed. |
| Compounded tirzepatide | $259 | Injection, floor priceAdvertised as 'As low as $259/mo' — a floor price only; no full per-dose ladder is disclosed. |
| Oral semaglutide | $199 | Tablet, floor priceAlso offered as an oral tablet at the same 'as low as' floor as the injection. |
| Oral tirzepatide | $259 | Tablet, floor priceAlso offered as an oral tablet at the same 'as low as' floor as the injection. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Mevo Health's public disclosures at last review and change often; confirm the current number on Mevo Health's own site.
What we like
- Names four real, checkable physicians rather than hiding behind generic 'licensed provider' language
- Both molecules offered as an oral tablet, not just injection
- A distinct, confirmed Delaware LLC — not an anonymous storefront
- LegitScript seal confirmed present
The caveats
- Only a floor ('as low as') price is disclosed — the real ladder and your actual cost aren't public
- No state-availability list published anywhere
- A consultation is required, but whether it's included in the price or billed separately isn't stated
- Two of its four named physicians also appear on other DTC telehealth brands' sites — an ordinary industry pattern, but worth knowing before assuming Mevo Health's team is exclusive to it
Mevo Health for mothers: our verdict
A Delaware-registered program naming four real physicians, with semaglutide and tirzepatide each offered as an injection or oral tablet from a disclosed floor price ($199/$259 'as low as') — but no full pricing ladder, no state list, and no confirmation the required consult is included. It runs about $199/month.
We weigh Mevo Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Mevo Health actually costs
- Compounded semaglutide — Injection, floor price: $199/mo
- Compounded tirzepatide — Injection, floor price: $259/mo
- Oral semaglutide — Tablet, floor price: $199/mo
- Oral tirzepatide — Tablet, floor price: $259/mo
That lands within a few dollars of the ~$175/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
The medications Mevo Health prescribes
Mevo Health prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Mevo Health fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Mevo Health is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want an oral tablet option and are comfortable getting an exact price in writing before committing, rather than seeing a full ladder published upfront.
Alternatives to Mevo Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Mevo Health
Head-to-head & alternatives
Mevo Health, answered
- How much does Mevo Health actually cost?
- Only a floor price is disclosed: 'as low as $199/mo' for semaglutide and 'as low as $259/mo' for tirzepatide, injection or oral tablet at the same floor. No full per-dose ladder is published, so your actual price depends on what a provider prescribes — get it in writing before you commit.
- Who prescribes at Mevo Health?
- Four named physicians, led by Dr. David Wasef, plus Dr. Frank Suppa, Dr. Andrew Sakla, and Dr. Constantin Chikando. Two of them also appear on other DTC telehealth brands' sites — a common industry pattern of physicians working across multiple platforms, not a sign Mevo Health is the same company as those brands.
- Which states does Mevo Health serve?
- Not published. There's no state-availability table and no '50 states' claim anywhere on the site — confirm directly before starting intake.
Pricing, states and verification reflect Mevo Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.